Brigatinib is a targeted cancer drug treatment for non small cell lung cancer (NSCLC). It is also…
Tepotinib is a kinase inhibitor directed against MET, including variants with exon 14 skipping - it…
Alectinib is a type of cancer growth blocker called a tyrosine kinase inhibitor. It works by…
Lorlatinib, sold under the brand name Pholorla100,Lorbrena in the United States, Canada, and Japan, and Lorviqua…
Lorlatinib, sold under the brand name Lorlatini,Lorbrena among others in the United States, Canada, and Japan,…
Mobocertinib is a small molecule tyrosine kinase inhibitor. Its molecular target is epidermal growth factor receptor (EGFR) bearing mutations in…
Aentrek(entrectinib) is used to treat a certain type of non-small cell lung cancer (NSCLC) in adults…